Zivo BioscienceZIVO 14 Pretax Margin % is -1,565.15% as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 944 Biotechnology companies, Zivo Bioscience ranks worse than 88.24% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Zivo Bioscience Pretax Margin % Related Terms
Zivo Bioscience Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Zivo Bioscience's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZIVO vs ATOS, QNCX, AEON: Pretax Margin % Comparison
For the Biotechnology subindustry, Zivo Bioscience's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience (ZIVO) has a Pretax Margin % of -1,565.15% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Zivo Bioscience and its competitors. According to the industry distribution chart, Zivo Bioscience ranks #833 out of 944 companies in the Biotechnology industry, placing it in the top 88.2%.
Is Zivo Bioscience's Pretax Margin % too high?
Zivo Bioscience's current Pretax Margin % is -1,565.15%. Based on the distribution chart, Zivo Bioscience ranks #833 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Pretax Margin % compare to ATOS and QNCX?
According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #833 out of 944 companies for Pretax Margin %. This places Zivo Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current Pretax Margin % is -1,565.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Pretax Margin % of -1,565.15%. The current Pretax Margin % is -1,565.15%. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Pretax Margin % is -1,565.15% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score
Get the complete analysis for ZIVO
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZIVO has been successfully added to your 
